Northern Trust Corp Nurix Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 566,855 shares of NRIX stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

566,855

Previous 438,089 29.39%

Holding current value

$11.2 Million

Previous $9.14 Million 39.19%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$18.93 - $25.69 $2.44 Million - $3.31 Million	128,766 Added 29.39%	566,855 $12.7 Million
Q2 2024 Aug 14, 2024	BUY	$12.02 - $21.3 $409,629 - $725,882	34,079 Added 8.44%	438,089 $9.14 Million
Q1 2024 May 14, 2024	SELL	$7.77 - $15.66 $99,487 - $200,510	-12,804 Reduced 3.07%	404,010 $5.94 Million
Q4 2023 Feb 13, 2024	SELL	$4.25 - $10.71 $102,161 - $257,446	-24,038 Reduced 5.45%	416,814 $4.3 Million
Q3 2023 Nov 13, 2023	BUY	$7.86 - $10.08 $95,970 - $123,076	12,210 Added 2.85%	440,852 $3.47 Million
Q2 2023 Aug 11, 2023	BUY	$8.7 - $13.28 $249,028 - $380,126	28,624 Added 7.16%	428,642 $4.28 Million
Q1 2023 May 15, 2023	SELL	$8.56 - $13.26 $67,838 - $105,085	-7,925 Reduced 1.94%	400,018 $3.55 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $41,421 - $61,292	4,201 Added 1.04%	407,943 $4.48 Million
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $191,706 - $308,005	15,548 Added 4.01%	403,742 $5.26 Million
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $659,217 - $1.24 Million	83,657 Added 27.47%	388,194 $4.92 Million
Q1 2022 May 13, 2022	SELL	$12.94 - $29.65 $148,602 - $340,500	-11,484 Reduced 3.63%	304,537 $4.27 Million
Q4 2021 Feb 08, 2022	SELL	$26.43 - $34.5 $131,753 - $171,982	-4,985 Reduced 1.55%	316,021 $9.15 Million
Q3 2021 Nov 15, 2021	BUY	$22.71 - $36.69 $547,674 - $884,816	24,116 Added 8.12%	321,006 $9.62 Million
Q2 2021 Aug 13, 2021	BUY	$24.21 - $35.89 $1.55 Million - $2.3 Million	64,213 Added 27.6%	296,890 $7.88 Million
Q1 2021 May 12, 2021	BUY	$26.98 - $50.17 $2.56 Million - $4.76 Million	94,865 Added 68.84%	232,677 $7.23 Million
Q4 2020 Feb 11, 2021	BUY	$22.85 - $48.44 $102,230 - $216,720	4,474 Added 3.36%	137,812 $4.53 Million
Q3 2020 Nov 16, 2020	BUY	$16.05 - $34.91 $2.14 Million - $4.65 Million	133,338 New	133,338 $4.65 Million

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $935M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Nurix Therapeutics, Inc. Transaction History